DYAI logo

Dyadic International, Inc.

DYAI

DYAI: Dyadic International Inc is a global biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

more

Show DYAI Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of DYAI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by DYAI's directors and management

Government lobbying spending instances

  • $20,000 Aug 14, 2007 Issue: Energy/Nuclear
U.S. Patents

New patents grants

  • Patent Title: Production of flu vaccine in Aug. 29, 2023
  • Patent Title: Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose Dec. 23, 2014
  • Patent Title: Transformation system in the field of filamentous fungal hosts Oct. 28, 2014
  • Patent Title: Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi Mar. 25, 2014
  • Patent Title: Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose Mar. 18, 2014
  • Patent Title: Bx11 enzymes having xylosidase activity Oct. 08, 2013
  • Patent Title: Methods and compositions for degradation of lignocellulosic material Nov. 06, 2012
  • Patent Title: Transformation system in the field of filamentous fungal hosts Sep. 18, 2012
  • Patent Title: Fungal enzymes Apr. 12, 2011
  • Patent Title: Expression-regulating sequences and expression products in the field of filamentous fungi Mar. 15, 2011
  • Patent Title: Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose Feb. 08, 2011
  • Patent Title: High-throughput screening of expressed dna libraries in filamentous fungi Sep. 14, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of DYAI in WallStreetBets Daily Discussion

DYAI News

Recent insights relating to DYAI

CNBC Recommendations

Recent picks made for DYAI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DYAI

Corporate Flights

Flights by private jets registered to DYAI